Institutional
Knoll Capital Management, LLC
CIK 0001325083
$180.2M
Reported AUM
37
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Knoll Capital Management, LLC · Q1 2026
AI · grounded in 13F
Knoll Capital Management, LLC exited its position in Avadel Pharmaceuticals Plc, a move totaling $12.93M. The fund also closed its holdings in GLD for $12.68M and SLV for $5.15M. To offset these exits, the manager established new positions in PHYS for $13.72M and PSLV for $5.42M. Additionally, the fund increased its stake in TFPM by 95.58% and FNV by 28%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | — | Biohaven Pharmactl Hldg Co | $19.7M | 10.93% | — | HELD |
| 2 | PHYS | Sprott physical gold Trust | $13.7M | 7.61% | +387,055 | NEW |
| 3 | RGLD | Royal Gold Inc. | $13.4M | 7.45% | — | HELD |
| 4 | MGTX | MeiraGTX Holdings | $10.8M | 6.01% | — | HELD |
| 5 | AEM | Agnico Eagle Mines Ltd | $10.7M | 5.94% | — | HELD |
| 6 | KGC | Kinross Gold Corp | $9.8M | 5.42% | -90,000 | -22.0% |
| 7 | ALDX | Aldeyra Therapeutics Inc | $9.3M | 5.14% | — | HELD |
| 8 | SA | SEABRIDGE GOLD INC | $9.0M | 4.99% | — | HELD |
| 9 | FNV | Franco Nev Corp | $7.9M | 4.39% | +7,000 | +28.0% |
| 10 | SSRM | SSR Mining In | $7.2M | 4.00% | — | HELD |
| 11 | ELTX | Elicio Therapeutics Inc | $6.7M | 3.74% | — | HELD |
| 12 | ENTX | Entera Bio Ltd | $6.5M | 3.59% | — | HELD |
| 13 | NUVB | Nuvation Bio Inc | $6.4M | 3.57% | — | HELD |
| 14 | CGAU | Centerra Gold Inc | $6.4M | 3.54% | -138,402 | -27.8% |
| 15 | PAAS | Pan American Silver | $5.5M | 3.03% | — | HELD |
| 16 | PSLV | Sprott Physical silver Trust | $5.4M | 3.01% | +222,160 | NEW |
| 17 | OCUL | Ocular Therapeutix Inc. | $5.1M | 2.82% | — | HELD |
| 18 | TFPM | Triple Flag Precious Metals | $4.0M | 2.22% | +56,200 | +95.6% |
| 19 | GROY | Gold RTY Corp | $3.6M | 1.99% | +1,000,000 | NEW |
| 20 | AGI | Alamos Gold Inc | $2.2M | 1.23% | — | HELD |
| 21 | ABEO | Abeona Therapeutics | $2.2M | 1.21% | +249,562 | +105.8% |
| 22 | NEWP | New Pac Metals Corp | $2.0M | 1.11% | — | HELD |
| 23 | CDE | Coeur Mining Inc | $1.8M | 1.00% | — | HELD |
| 24 | ITA | iSHares US Aerospace & Defense | $1.7M | 0.93% | — | HELD |
| 25 | PM | Philip Morris Intl. Inc | $1.7M | 0.92% | — | HELD |
| 26 | WPM | Wheaton Precious Metals Corp | $1.6M | 0.91% | — | HELD |
| 27 | NOC | Northrop Grumman Corp | $1.5M | 0.82% | — | HELD |
| 28 | BAH | Booz Allen Hamilton HLDG COR | $1.0M | 0.56% | — | HELD |
| 29 | ELE | Elemental RTY Corp | $943K | 0.52% | +50,000 | NEW |
| 30 | VMET | Versamet Royalties Corp | $634K | 0.35% | +66,621 | NEW |
| 31 | DC | Dakota Gold Corp | $621K | 0.34% | — | HELD |
| 32 | AMRZ | Amrize LTD | $514K | 0.29% | +9,175 | NEW |
| 33 | ALT | Altimmune Inc | $493K | 0.27% | -961,524 | -85.7% |
| 34 | CRDL | Cardiol Therapeutics Inc | $135K | 0.07% | — | HELD |
| 35 | PHAR | Pharming Group NV | $68K | 0.04% | +4,057 | NEW |
| 36 | — | Orgenesis, Inc. | $30K | 0.02% | — | HELD |
| 37 | OR | OR Royalties | $9K | 0.00% | +225,000 | NEW |
| 38 | — | Avadel Pharmaceuticals Plc | — | — | -600,000 | EXITED |
| 39 | GLD | SPDR Gold Trust | — | — | -32,000 | EXITED |
| 40 | SLV | iShares Silver Trust | — | — | -80,000 | EXITED |
| 41 | APLT | Applied Therapeutics Inc | — | — | -6,050,000 | EXITED |
Source: SEC EDGAR · accession 0001104659-26-062445. 13F discloses long positions only — shorts, foreign equities, and options are excluded.